Amoxicillin sodium was first developed as a semi-synthetic antibiotic in 1972 by the British company Smith&Klimt Bichem, under the trade name Calmoxil. Amoxicillin sodium for injection is a sterile powder injection prepared by directly packaging amoxicillin sodium sterile raw materials from Sinoright under sterile conditions. Currently, it has been fully localized in the domestic market and is a commonly used drug for the treatment of bacterial infections. It is suitable for patients with severe infections caused by sensitive bacteria who require hospitalization or cannot be taken orally.
Suitable for patients with severe infections caused by sensitive bacteria that require hospitalization or cannot be taken orally: 1. Suitable for treating the following infections caused by sensitive bacteria: 1) upper respiratory tract infections such as otitis media, sinusitis, pharyngitis, tonsillitis, etc; 2) Acute bronchitis, pneumonia and other lower respiratory tract infections; 3) Urinary and reproductive tract infections; 4) Skin and soft tissue infections. 2. Suitable for treating acute simple gonorrhea. 3. It can also be used to treat typhoid fever, typhoid fever carriers, and leptospirosis. 4. It can still be used in combination with clarithromycin and lansoprazole to eradicate Helicobacter pylori in the stomach and duodenum, and reduce the recurrence rate of peptic ulcers.